Tokyo Tape
Sign in
← Ain Holdings

Annual report

9627.TEDINET S100WFSA
Period2024-05-01 → 2025-04-30
Filed2025-07-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥456.8bn2024-05-01 → 2025-04-30Cons.Net sales
Revenue¥399.8bn2023-05-01 → 2024-04-30Cons.Net sales
Revenue¥358.7bn2022-05-01 → 2023-04-30vCons.Net sales (5-year summary)
Revenue¥316.2bn2021-05-01 → 2022-04-30vCons.Net sales (5-year summary)
Revenue¥297.3bn2020-05-01 → 2021-04-30dCons.Net sales (5-year summary)
Operating income¥16.9bn2024-05-01 → 2025-04-30Cons.Operating income
Operating income¥20.4bn2023-05-01 → 2024-04-30Cons.Operating income
Ordinary income¥18.1bn2024-05-01 → 2025-04-30Cons.Ordinary income
Ordinary income¥21.4bn2023-05-01 → 2024-04-30Cons.Ordinary income
Ordinary income¥17.1bn2022-05-01 → 2023-04-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥16.0bn2021-05-01 → 2022-04-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥12.6bn2020-05-01 → 2021-04-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥16.7bn2024-05-01 → 2025-04-30Cons.Income before income taxes
Profit before tax¥19.1bn2023-05-01 → 2024-04-30Cons.Income before income taxes
Net income (owners)¥9.3bn2024-05-01 → 2025-04-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.4bn2023-05-01 → 2024-04-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.2bn2022-05-01 → 2023-04-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥7.1bn2021-05-01 → 2022-04-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.7bn2020-05-01 → 2021-04-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥9.3bn2024-05-01 → 2025-04-30Cons.Profit loss
Net income¥11.4bn2023-05-01 → 2024-04-30Cons.Profit loss
Total assets¥311.9bnat 2025-04-30Cons.Assets
Total assets¥249.4bnat 2024-04-30Cons.Assets
Total assets¥231.8bnat 2023-04-30vCons.Total assets (5-year summary)
Total assets¥212.5bnat 2022-04-30vCons.Total assets (5-year summary)
Total assets¥203.7bnat 2021-04-30dCons.Total assets (5-year summary)
Total liabilities¥169.3bnat 2025-04-30Cons.Liabilities
Total liabilities¥114.0bnat 2024-04-30Cons.Liabilities
Net assets / equity¥142.6bnat 2025-04-30Cons.Net assets
Net assets / equity¥135.4bnat 2024-04-30Cons.Net assets
Net assets / equity¥126.5bnat 2023-04-30vCons.Net assets
Net assets / equity¥119.0bnat 2022-04-30vCons.Net assets (5-year summary)
Net assets / equity¥115.8bnat 2021-04-30dCons.Net assets (5-year summary)
Cash and deposits¥26.9bnat 2025-04-30Cons.Cash and deposits
Cash and deposits¥48.6bnat 2024-04-30Cons.Cash and deposits
Cash & equivalents¥26.7bnat 2025-04-30Cons.Cash and cash equivalents
Cash & equivalents¥48.4bnat 2024-04-30Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2023-04-30vCons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30vCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥55.0bnat 2021-04-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥23.1bn2024-05-01 → 2025-04-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.0bn2023-05-01 → 2024-04-30Cons.Net cash provided by used in operating activities
Operating cash flow¥20.3bn2022-05-01 → 2023-04-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥26.2bn2021-05-01 → 2022-04-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.9bn2020-05-01 → 2021-04-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥65.9bn2024-05-01 → 2025-04-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥15.7bn2023-05-01 → 2024-04-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥22.3bn2022-05-01 → 2023-04-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13.9bn2021-05-01 → 2022-04-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.5bn2020-05-01 → 2021-04-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥21.1bn2024-05-01 → 2025-04-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.1bn2023-05-01 → 2024-04-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥11.2bn2022-05-01 → 2023-04-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥7.8bn2021-05-01 → 2022-04-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.6bn2020-05-01 → 2021-04-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥264.322024-05-01 → 2025-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥324.642023-05-01 → 2024-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥262.872022-05-01 → 2023-04-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥201.472021-05-01 → 2022-04-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥189.042020-05-01 → 2021-04-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥4,063.53at 2025-04-30Cons.Net assets per share (5-year summary)
Net assets per share¥3,866.55at 2024-04-30Cons.Net assets per share (5-year summary)
Net assets per share¥3,599.47at 2023-04-30vCons.Net assets per share (5-year summary)
Net assets per share¥3,385.51at 2022-04-30vCons.Net assets per share (5-year summary)
Net assets per share¥3,267.49at 2021-04-30dCons.Net assets per share (5-year summary)
Equity ratio45.7%at 2025-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio54.3%at 2024-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio54.6%at 2023-04-30vCons.Equity to asset ratio (5-year summary)
Equity ratio56.0%at 2022-04-30vCons.Equity to asset ratio (5-year summary)
Equity ratio56.8%at 2021-04-30dCons.Equity to asset ratio (5-year summary)
ROE6.7%2024-05-01 → 2025-04-30Cons.Rate of return on equity (5-year summary)
ROE8.7%2023-05-01 → 2024-04-30Cons.Rate of return on equity (5-year summary)
ROE7.5%2022-05-01 → 2023-04-30vCons.Rate of return on equity (5-year summary)
ROE6.0%2021-05-01 → 2022-04-30vCons.Rate of return on equity (5-year summary)
ROE5.9%2020-05-01 → 2021-04-30dCons.Rate of return on equity (5-year summary)
Employees13,009at 2025-04-30Cons.Number of employees
Employees11,474at 2024-04-30Cons.Number of employees
Employees10,651at 2023-04-30vCons.Number of employees
Employees9,568at 2022-04-30vCons.Number of employees
Employees9,019at 2021-04-30dCons.Number of employees
Revenue¥17.7bn2024-05-01 → 2025-04-30StandaloneOperating revenue1
Revenue¥14.1bn2023-05-01 → 2024-04-30StandaloneOperating revenue1
Revenue¥12.8bn2022-05-01 → 2023-04-30vStandaloneOperating revenue1 (5-year summary)
Revenue¥11.5bn2021-05-01 → 2022-04-30vStandaloneOperating revenue1 (5-year summary)
Revenue¥11.6bn2020-05-01 → 2021-04-30dStandaloneOperating revenue1 (5-year summary)
Operating income¥7.2bn2024-05-01 → 2025-04-30StandaloneOperating income
Operating income¥5.1bn2023-05-01 → 2024-04-30StandaloneOperating income
Ordinary income¥7.2bn2024-05-01 → 2025-04-30StandaloneOrdinary income
Ordinary income¥5.3bn2023-05-01 → 2024-04-30StandaloneOrdinary income
Ordinary income¥5.0bn2022-05-01 → 2023-04-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.2bn2021-05-01 → 2022-04-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥6.3bn2020-05-01 → 2021-04-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥7.2bn2024-05-01 → 2025-04-30StandaloneIncome before income taxes
Profit before tax¥5.1bn2023-05-01 → 2024-04-30StandaloneIncome before income taxes
Net income¥6.9bn2024-05-01 → 2025-04-30StandaloneProfit loss
Net income¥4.9bn2023-05-01 → 2024-04-30StandaloneProfit loss
Net income¥4.9bn2022-05-01 → 2023-04-30vStandaloneNet income loss (5-year summary)
Net income¥5.0bn2021-05-01 → 2022-04-30vStandaloneNet income loss (5-year summary)
Net income¥6.1bn2020-05-01 → 2021-04-30dStandaloneNet income loss (5-year summary)
Total assets¥181.7bnat 2025-04-30StandaloneAssets
Total assets¥146.2bnat 2024-04-30StandaloneAssets
Total assets¥143.8bnat 2023-04-30vStandaloneTotal assets (5-year summary)
Total assets¥140.2bnat 2022-04-30vStandaloneTotal assets (5-year summary)
Total assets¥136.4bnat 2021-04-30dStandaloneTotal assets (5-year summary)
Total liabilities¥93.6bnat 2025-04-30StandaloneLiabilities
Total liabilities¥62.7bnat 2024-04-30StandaloneLiabilities
Net assets / equity¥88.1bnat 2025-04-30StandaloneNet assets
Net assets / equity¥83.5bnat 2024-04-30StandaloneNet assets
Net assets / equity¥81.3bnat 2023-04-30vStandaloneNet assets
Net assets / equity¥78.2bnat 2022-04-30vStandaloneNet assets (5-year summary)
Net assets / equity¥77.3bnat 2021-04-30dStandaloneNet assets (5-year summary)
Cash and deposits¥9.3bnat 2025-04-30StandaloneCash and deposits
Cash and deposits¥34.0bnat 2024-04-30StandaloneCash and deposits
EPS (basic)¥197.892024-05-01 → 2025-04-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥140.652023-05-01 → 2024-04-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥139.462022-05-01 → 2023-04-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥141.152021-05-01 → 2022-04-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥172.162020-05-01 → 2021-04-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥802024-05-01 → 2025-04-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥802023-05-01 → 2024-04-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥602022-05-01 → 2023-04-30vStandaloneDividend paid per share (5-year summary)
Dividend per share¥552021-05-01 → 2022-04-30vStandaloneDividend paid per share (5-year summary)
Dividend per share¥552020-05-01 → 2021-04-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,512.96at 2025-04-30StandaloneNet assets per share (5-year summary)
Net assets per share¥2,386.57at 2024-04-30StandaloneNet assets per share (5-year summary)
Net assets per share¥2,313.07at 2023-04-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,227.25at 2022-04-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,180.74at 2021-04-30dStandaloneNet assets per share (5-year summary)
Equity ratio48.5%at 2025-04-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio57.1%at 2024-04-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio56.5%at 2023-04-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio55.8%at 2022-04-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio56.6%at 2021-04-30dStandaloneEquity to asset ratio (5-year summary)
ROE8.1%2024-05-01 → 2025-04-30StandaloneRate of return on equity (5-year summary)
ROE6.0%2023-05-01 → 2024-04-30StandaloneRate of return on equity (5-year summary)
ROE6.1%2022-05-01 → 2023-04-30vStandaloneRate of return on equity (5-year summary)
ROE6.4%2021-05-01 → 2022-04-30vStandaloneRate of return on equity (5-year summary)
ROE8.1%2020-05-01 → 2021-04-30dStandaloneRate of return on equity (5-year summary)
Shares issued35,428,212at 2025-04-30StandaloneTotal number of issued shares (5-year summary)
Shares issued35,428,212at 2024-04-30StandaloneTotal number of issued shares (5-year summary)
Shares issued35,428,212at 2023-04-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued35,428,212at 2022-04-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued35,428,212at 2021-04-30dStandaloneTotal number of issued shares (5-year summary)
Employees169at 2025-04-30StandaloneNumber of employees
Employees162at 2024-04-30StandaloneNumber of employees
Employees161at 2023-04-30vStandaloneNumber of employees
Employees160at 2022-04-30vStandaloneNumber of employees
Employees156at 2021-04-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 66
SegmentItemPeriodValue
Otherother segmentscapex2024-05-01 → 2025-04-30¥80m
Otherother segmentsdepreciation2024-05-01 → 2025-04-30¥318m
Otherother segmentsrevenue2024-05-01 → 2025-04-30¥11.0bn
Otherother segmentsrevenue external2024-05-01 → 2025-04-30¥11.0bn
Otherother segmentsrevenue intersegment2024-05-01 → 2025-04-30¥54m
Otherother segmentssegment assetsat 2025-04-30¥9.8bn
Otherother segmentssegment ordinary income2024-05-01 → 2025-04-30¥4m
Reconciling Itemsreconcilingcapex2024-05-01 → 2025-04-30¥2.8bn
Reconciling Itemsreconcilingdepreciation2024-05-01 → 2025-04-30¥1.4bn
Reconciling Itemsreconcilingrevenue2024-05-01 → 2025-04-30−¥54m
Reconciling Itemsreconcilingrevenue intersegment2024-05-01 → 2025-04-30−¥54m
Reconciling Itemsreconcilingsegment assetsat 2025-04-30¥51.4bn
Reconciling Itemsreconcilingsegment ordinary income2024-05-01 → 2025-04-30−¥11.0bn
Dispensing Pharmacyreportable segmentcapex2024-05-01 → 2025-04-30¥7.2bn
Dispensing Pharmacyreportable segmentdepreciation2024-05-01 → 2025-04-30¥4.2bn
Dispensing Pharmacyreportable segmentemployeesat 2025-04-3011119 pure
Dispensing Pharmacyreportable segmentrevenue2024-05-01 → 2025-04-30¥384.8bn
Dispensing Pharmacyreportable segmentrevenue external2024-05-01 → 2025-04-30¥384.8bn
Dispensing Pharmacyreportable segmentsegment assetsat 2025-04-30¥216.8bn
Dispensing Pharmacyreportable segmentsegment ordinary income2024-05-01 → 2025-04-30¥24.3bn
Drug And Cosmetic Storereportable segmentcapex2024-05-01 → 2025-04-30¥2.4bn
Drug And Cosmetic Storereportable segmentdepreciation2024-05-01 → 2025-04-30¥1.3bn
Drug And Cosmetic Storereportable segmentemployeesat 2025-04-301231 pure
Drug And Cosmetic Storereportable segmentrevenue2024-05-01 → 2025-04-30¥61.0bn
Drug And Cosmetic Storereportable segmentrevenue external2024-05-01 → 2025-04-30¥61.0bn
Drug And Cosmetic Storereportable segmentsegment assetsat 2025-04-30¥34.0bn
Drug And Cosmetic Storereportable segmentsegment ordinary income2024-05-01 → 2025-04-30¥4.8bn
—segment totalcapex2024-05-01 → 2025-04-30¥9.7bn
—segment totaldepreciation2024-05-01 → 2025-04-30¥5.9bn
—segment totalrevenue2024-05-01 → 2025-04-30¥456.9bn
—segment totalrevenue external2024-05-01 → 2025-04-30¥456.8bn
—segment totalrevenue intersegment2024-05-01 → 2025-04-30¥54m
—segment totalsegment assetsat 2025-04-30¥260.5bn
—segment totalsegment ordinary income2024-05-01 → 2025-04-30¥29.1bn
Otherother segmentscapex2023-05-01 → 2024-04-30¥1.0bn
Otherother segmentsdepreciation2023-05-01 → 2024-04-30¥279m
Otherother segmentsrevenue2023-05-01 → 2024-04-30¥11.2bn
Otherother segmentsrevenue external2023-05-01 → 2024-04-30¥11.1bn
Otherother segmentsrevenue intersegment2023-05-01 → 2024-04-30¥54m
Otherother segmentssegment assetsat 2024-04-30¥10.4bn
Otherother segmentssegment ordinary income2023-05-01 → 2024-04-30¥47m
Reconciling Itemsreconcilingcapex2023-05-01 → 2024-04-30¥2.3bn
Reconciling Itemsreconcilingdepreciation2023-05-01 → 2024-04-30¥1.0bn
Reconciling Itemsreconcilingrevenue2023-05-01 → 2024-04-30−¥54m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2024-04-30−¥54m
Reconciling Itemsreconcilingsegment assetsat 2024-04-30¥3.9bn
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2024-04-30−¥9.4bn
Dispensing Pharmacyreportable segmentcapex2023-05-01 → 2024-04-30¥8.0bn
Dispensing Pharmacyreportable segmentdepreciation2023-05-01 → 2024-04-30¥3.7bn
Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2024-04-30¥357.6bn
Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2024-04-30¥357.6bn
Dispensing Pharmacyreportable segmentsegment assetsat 2024-04-30¥219.7bn
Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2024-04-30¥27.6bn
Drug And Cosmetic Storereportable segmentcapex2023-05-01 → 2024-04-30¥1.4bn
Drug And Cosmetic Storereportable segmentdepreciation2023-05-01 → 2024-04-30¥438m
Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2024-04-30¥31.1bn
Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2024-04-30¥31.1bn
Drug And Cosmetic Storereportable segmentsegment assetsat 2024-04-30¥15.4bn
Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2024-04-30¥3.1bn
—segment totalcapex2023-05-01 → 2024-04-30¥10.5bn
—segment totaldepreciation2023-05-01 → 2024-04-30¥4.4bn
—segment totalrevenue2023-05-01 → 2024-04-30¥399.9bn
—segment totalrevenue external2023-05-01 → 2024-04-30¥399.8bn
—segment totalrevenue intersegment2023-05-01 → 2024-04-30¥54m
—segment totalsegment assetsat 2024-04-30¥245.5bn
—segment totalsegment ordinary income2023-05-01 → 2024-04-30¥30.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,668
ItemContextValueUnit
Amortization of goodwill segment informationCurrentYearDuration_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember1363000000JPY
Amortization of goodwill segment informationCurrentYearDuration_OtherReportableSegmentsMember140000000JPY
Amortization of goodwill segment informationCurrentYearDuration_ReportableSegmentsMember5796000000JPY
Amortization of goodwill segment informationCurrentYearDuration_ReconcilingItemsMember－JPY
Amortization of goodwill segment informationCurrentYearDuration5796000000JPY
Impairment loss elCurrentYearDuration_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember1572000000JPY
Impairment loss elCurrentYearDuration_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember211000000JPY
Impairment loss elCurrentYearDuration_OtherReportableSegmentsMember21000000JPY
Impairment loss elCurrentYearDuration_ReportableSegmentsMember1805000000JPY
Impairment loss elCurrentYearDuration_ReconcilingItemsMember43000000JPY
Impairment loss elCurrentYearDuration1848000000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember7213000000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember2371000000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_OtherReportableSegmentsMember80000000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_ReportableSegmentsMember9664000000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_ReconcilingItemsMember2838000000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration12502000000JPY
Amortization of goodwill segment informationPrior1YearDuration_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember4274000000JPY
Amortization of goodwill segment informationPrior1YearDuration_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember5000000JPY
Amortization of goodwill segment informationPrior1YearDuration_OtherReportableSegmentsMember140000000JPY
Amortization of goodwill segment informationPrior1YearDuration_UnallocatedAmountsAndEliminationMember－JPY
Amortization of goodwill segment informationPrior1YearDuration4421000000JPY
GoodwillPrior1YearInstant_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember43306000000JPY
GoodwillPrior1YearInstant_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
GoodwillPrior1YearInstant_OtherReportableSegmentsMember760000000JPY
GoodwillPrior1YearInstant_UnallocatedAmountsAndEliminationMember－JPY
GoodwillPrior1YearInstant44066000000JPY
Amortization of goodwill segment informationCurrentYearDuration_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember4292000000JPY
Amortization of goodwill segment informationCurrentYearDuration_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember1363000000JPY
Amortization of goodwill segment informationCurrentYearDuration_OtherReportableSegmentsMember140000000JPY
Amortization of goodwill segment informationCurrentYearDuration_UnallocatedAmountsAndEliminationMember－JPY
Amortization of goodwill segment informationCurrentYearDuration5796000000JPY
GoodwillCurrentYearInstant_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember44468000000JPY
GoodwillCurrentYearInstant_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember39685000000JPY
GoodwillCurrentYearInstant_OtherReportableSegmentsMember619000000JPY
GoodwillCurrentYearInstant_UnallocatedAmountsAndEliminationMember－JPY
GoodwillCurrentYearInstant84772000000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember33975000000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember9315000000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember1024000000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember887000000JPY
Short term loans receivablePrior1YearInstant_NonConsolidatedMember10898000000JPY
Short term loans receivableCurrentYearInstant_NonConsolidatedMember14651000000JPY
Accounts receivable otherPrior1YearInstant_NonConsolidatedMember1893000000JPY
Accounts receivable otherCurrentYearInstant_NonConsolidatedMember1288000000JPY
Other caPrior1YearInstant_NonConsolidatedMember0JPY
Other caCurrentYearInstant_NonConsolidatedMember1000000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember47792000000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember26144000000JPY
Buildings netPrior1YearInstant_NonConsolidatedMember1345000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2024-04-30pass
balance sheet identityconsolidated 2025-04-30pass rounding
balance sheet identitynon_consolidated 2024-04-30pass rounding
balance sheet identitynon_consolidated 2025-04-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-04-30pass
statement vs summary · net assetsconsolidated 2024-04-30pass
statement vs summary · net assetsconsolidated 2025-04-30pass
statement vs summary · net assetsnon_consolidated 2023-04-30pass
statement vs summary · net assetsnon_consolidated 2024-04-30pass
statement vs summary · net assetsnon_consolidated 2025-04-30pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2024-04-30pass
statement vs summary · net income attributable to parentconsolidated 2024-05-01/2025-04-30pass
statement vs summary · operating cash flowconsolidated 2023-05-01/2024-04-30pass
statement vs summary · operating cash flowconsolidated 2024-05-01/2025-04-30pass
statement vs summary · revenueconsolidated 2023-05-01/2024-04-30pass
statement vs summary · revenueconsolidated 2024-05-01/2025-04-30pass
statement vs summary · revenuenon_consolidated 2023-05-01/2024-04-30pass
statement vs summary · revenuenon_consolidated 2024-05-01/2025-04-30pass
statement vs summary · total assetsconsolidated 2024-04-30pass
statement vs summary · total assetsconsolidated 2025-04-30pass
statement vs summary · total assetsnon_consolidated 2024-04-30pass
statement vs summary · total assetsnon_consolidated 2025-04-30pass